Prognostic significance of the number of lymph nodes removed at lobectomy in stage IA non-small cell lung cancer

Journal of Thoracic Oncology

Volumn 3, Issue 8, 2008, Pages 880-886

  Ou, Sai Hong Ignatius ^a,b   Zell, Jason A ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Lobectomy; Number of lymph nodes; Overall survival; Prognosis; Stage IA NSCLC

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER REGISTRY; CANCER STAGING; CANCER SURVIVAL; CAUSE OF DEATH; CHILD; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INFANT; LUNG LOBECTOMY; LUNG NON SMALL CELL CANCER; LUNG RESECTION; LYMPH NODE; LYMPHADENECTOMY; MAJOR CLINICAL STUDY; MALE; MARRIAGE; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; SOCIAL STATUS; UNITED STATES; LUNG TUMOR; MIDDLE AGED; NEWBORN; PATHOLOGY; PRESCHOOL CHILD; RETROSPECTIVE STUDY; SURVIVAL RATE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, NON-SMALL-CELL LUNG; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; LUNG NEOPLASMS; LYMPH NODE EXCISION; LYMPH NODES; MALE; MIDDLE AGED; NEOPLASM STAGING; PNEUMONECTOMY; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 58149128166     PISSN: 15560864     EISSN: 15561380     Source Type: Journal    
DOI: 10.1097/JTO.0b013e31817dfced     Document Type: Article

References (29)

1. Kamangar F, Dores GM, Anderson WF. Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world. J Clin Oncol 2006;24:2137-2150.
2. Fry WA, Philips JL, Menck HR. Ten-year survey of lung cancer treatment and survival in hospitals in the United States: a national cancer data base report. Cancer 1999;86:1867-1876.
3. Ginsberg RJ, Rubinstein LV. Randomized trial of lobectomy versus limited resection for T1N0 non-small cell lung cancer. Ann Thorac Surg 1995;60:615-623.
4. Pisters KMW, Evans WK, Azzoli CG, et al. Cancer care ontario and American society of clinical oncology adjuvant chemotherapy and adjuvant radiation therapy for stages I-IIIA resectable non-small cell lung cancer guideline. J Clin Oncol 2007;25:5506-5518.
5. Barnard J, Dunning J, Musleh G, et al. Is there a role for the use of radical lymph node dissection in the surgical management of respectable non-small cell lung cancer? Interact CardioVasc Thorac Surg 2004;3: 294-299.
6. Ludwig MS, Goodman M, Miller DL, et al. Postoperative survival and the number of lymph nodes sampled during resection of node-negative non-small cell lung cancer. Chest 2005;128:1545-1550.
7. Keller SM, Adak S, Wagner H, et al. Mediastinal lymph node dissection improves survival in patients with stages II and IIIa non-small cell lung cancer. Ann Thorac Surg 2000;70:358-366.
8. Sawyer T, Bonner JA, Gould PM. Patients with stage I non-small cell lung carcinoma at post-operative risk for local recurrence, distant metastasis, and death. Implications related to design of clinical trials. Int J Radiat Oncol Biol Phys 1999;45:315-321.
9. Gajra A, Newman N, Gamble GP, et al. Effect of number of lymph nodes sampled on outcome in patients with stage I non-small-cell lung cancer. J Clin Oncol 2003;21:1029-1034.
10. Wu Y-C, Lin C-FJ, Hsu W-H, et al. Long term results of pathological stage I non-small cell lung cancer: validation of using the number of totally removed lymph nodes as a staging control. Eur J Cardiothorac Surg 2003;24:994-1001.
11. Doddili C, Aragon A, Barlesi F, et al. Does the extent of lymph node dissection influence outcome in patients with stage I non-small-cell lung cancer? Eur J Cardiothorac Surg 2005;27:680-685.
12. Lardinois D, Suter H, Hakki H, et al. Morbidity, survival and site of recurrence after mediastinal lymph-node versus systematic sampling after complete resection for non-small cell lung cancer. Ann Thorac Surg 2005;80:268-275.
13. Sugi K, Nawata K, Fujita N, et al. Systemic lymph node dissection for clinically diagnosed peripheral non-small cell lung cancer less than 2 cm in diameter. World J Surg 1998;22:290-294.
14. Izbicki JR, Passlick BM, Pantel K, et al. Effectiveness of radical systematic mediastinal lymphadenectomy in patients with resectable non-small cell lung cancer. Ann Surg 1998;227:138-144.
15. Wu YL, Huang ZF, Wang SY, et al. A randomized trial of systematic nodal dissection in resectable non-small cell lung cancer. Lung Cancer 2002;36:1-6.
16. Ou S-HI, Zell JA, Ziogas A, Anton-Culver H. Prognostic factors for survival of stage I non-small cell lung cancer (NSCLC) patients: a population-based analysis of 19,702 stage I patients in the California Cancer Registry (CCR) from 1989-2003. Cancer 2007;110:1532-1541.
17. Zell JA, Ou S-HI, Ziogas A, et al. Epidemiology of bronchioloalveolar carcinoma: improvement in survival after release of the 1999 WHO classification of lung tumors. J Clin Oncol 2005;23:8396-8405.
18. Yost K, Perkins C, Cohen R, Morris C, Wright W. Socioeconomic status and breast cancer incidence in California for different race/ethnic groups. Cancer Causes Control 2001;12:703-711.
19. Sigurdson ER. Lymph node dissection: is it diagnostic or therapeutic? J Clin Oncol 2003;21:965-967.
20. Chang GL, Rodriguez-Bigas MA, Skibber JM, et al. Lymph node evaluation and survival after curative resection of colon cancer: systemic review. J Natl Cancer Inst 2007;99:433-441.
21. Berger AC, Sigurdson ER, LeVoyer T, et al. Colon cancer survival is associated with decreasing ratio of metastatic to examined lymph nodes. J Clin Oncol 2005;23:8706-8712.
22. Smith DD, Schwarz RR, Schwarz RE. Impact of total lymph node count on staging and survival after gastrectomy for gastric cancer: data from a large US-population database. J Clin Oncol 2005;23:7114-7124.
23. Schwarz RE, Smith DD. Extent of lymph node retrieval and pancreatic cancer survival: information from a large US population database. Ann Surg Oncol 2006;13:1189-1200.
24. Goldstraw P, Crowley J, Chansky K, et al. The IASLC lung cancer staging project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM classification of malignant tumours. J Thorac Oncol 2007;2:706-714.
25. Potti A, Mukherjee S, Petersen R, et al. A genomic strategy to refine prognosis in early-stage non-small-cell lung cancer. N Engl J Med 2006;355:570-580.
26. Kobayashi N, Toyooka S, Soh J, et al. Risk factors for recurrence and unfavorable prognosis in patients with stage I non-small cell lung cancer and a tumor diameter of 20mm or less. J Thorac Oncol 2007;2:808-812.
27. Ou S-HI, Zell JA, Ziogas A, Anton-Culver H. Low socioeconomic status is an independent poor prognostic factor for survival in stage I non-small-cell lung cancer, and is independent of marital status, race and surgical treatment. A population-based analysis of 19,702 stage I NSCLC patients in the California Cancer Registry. Cancer 2008;112: 2011-2020.
28. Raz DJ, Zell JA, Ou SH, Gandara DR, Anton-Culver H, Jablons DM. Natural history of stage I non-small cell lung cancer: implications for early detection. Chest 2007;132:193-199.
29. Allen MS, Darling DE, Pechet TT, et al. Morbiditiy and mortality of major resections in patients with early-stage lung cancer: initial results of the randomized, prospective ACOSOG Z0030 trial. Ann Thorac Surg 2006;81:1013-1020.